CYRX News and Press, CryoPort Inc. From 12/01/23

2023-12-01 12:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-29 15:06:19 ET Summary BioLife Solutions, Inc. is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. The company offers bioproduction tools and services for the cell and gene therapy industry, with recurring revenue streams ma...

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services PR Newswire Companies Will Partner to Provide Complete Supply Chain Solutions for the Life Science and Biopharmaceutical Industries NASHVI...

2023-11-16 09:39:00 ET More on CryoPort Cryoport, Inc. (CYRX) Q3 2023 Earnings Call Transcript Cryoport: Great Potential That Management Continues To Fail To Actualize Cryoport to establish first U.K. logistics center Seeking Alpha’s Quant Rating on Cr...

Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express PR Newswire CRYOPDP's Acquisition of Bluebird Express Adds Further Domestic and International Transportation Services Strengthening CRYOPDP's U.S. Logistics Operations NASHVILLE, Tenn. ...

2023-11-09 00:18:09 ET Cryoport, Inc. (CYRX) Q3 2023 Earnings Conference Call November 8, 2023 17:00 ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki -...

2023-11-08 16:13:40 ET More on CryoPort Cryoport: Great Potential That Management Continues To Fail To Actualize Cryoport to establish first U.K. logistics center Morgan Stanley starts Cryoport at equal weight, cites attractive fundamentals Seeking Alpha ...

Cryoport Reports Third Quarter 2023 Financial Results PR Newswire Third quarter 2023 commercial Cell and Gene Therapy revenue up 54% year-over-year Supporting a record total of 670 clinical trials worldwide, with 81 in Phase 3 Nine months 2023 revenue of $1...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

2023-11-08 04:55:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. Headwaters Capital Management's portfolio declined by 7.6% in Q3 2023, compared to a 4.7% return for the Russell Mi...